Unknown EARLY_PHASE1 INTERVENTIONAL NCT00656552

Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation

Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation A Double-Blind, Placebo-Controlled, Fixed-Dose,Randomized Controlled Study

Sponsor: Cairo University

Conditions Premature Ejaculation

Interventions Escitalopram

Updated 6 times since 2017 Last updated: Apr 10, 2008 Started: May 31, 2008 Primary completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00656552, this EARLY_PHASE1 trial focuses on Premature Ejaculation and remains ongoing. Sponsored by Cairo University, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Unknown Status EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status Phase 0

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt